EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcome.
<h4>Purpose</h4>Extracellular matrix metalloproteinase inducer (EMMPRIN) has been reported to play crucial roles, including in angiogenesis, in several carcinomas. However, the correlation between EMMPRIN levels and angiogenesis expression profile has not been reported, and the role of E...
Enregistré dans:
Auteurs principaux: | Mototaka Sato, Yasutomo Nakai, Wataru Nakata, Takahiro Yoshida, Koji Hatano, Atsunari Kawashima, Kazutoshi Fujita, Motohide Uemura, Hitoshi Takayama, Norio Nonomura |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/58d32f8a4b1a491a86c5c6f79d163574 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Decreased renal function increases the nighttime urine volume rate by carryover of salt excretion to the nighttime
par: Kentaro Takezawa, et autres
Publié: (2021) -
Sunitinib for advanced renal cell cancer
par: Chris Coppin
Publié: (2008) -
Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
par: Hiroki Tsujinaka, et autres
Publié: (2020) -
EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2.
par: Faten Bougatef, et autres
Publié: (2010) -
Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma.
par: Stephan Ursprung, et autres
Publié: (2021)